Drug Trial Radar · NCT06774664
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
Last checked: Nov 19, 2026Latest source record: Jan 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
99
Planned (sponsor's estimate)
Start
Jan 2025
Primary completion
Sep 2027
Study completion Mar 2029
Sponsor
- Lead sponsor
- Sinocelltech Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SCTC21C in subjects with plasma cell-driven autoimmune diseases
Conditions
- IgA Nephropathy
Interventions
SCTC21CBiological
Drug: SCTC21C Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: Treatment-emergent adverse events (TEAEs), serious adverse events (SAEs).Time frame: 36 Weeks
- Phase 2: Percentage change in urine protein-to-creatinine ratio (UPCR) at Week 24 compared to baselineTime frame: 24 Weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Baotou Medical College
Baotou, China
Beijing Tsinghua Changgung Hospital
Beijing, China
Peking University First Hospital
Beijing, China
Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital
Chengdu, China
Guangdong Provincial People's Hospital
Guangzhou, China
The First Affliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Zhejiang Provincial People's Hospital
Hangzhou, China
Shandong Provincial Hospital
Jinan, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
The Second Affiliated Hospital of Nanchang University
Nanchang, China
Guangxi Zhuang Autonomous Region People's Hospital
Nanning, China
Ningbo NO.2 Hospital
Ningbo, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
Shanghai General Hospital
Shanghai, China
Wuxi People's Hospital
Wuxi, China
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi'an, China
The First Affiliated Hospital of Xiamen University
Xiamen, China
The Second Affiliated Hospital of Xingtai Medical College
Xingtai, China
Yantai Yuhuangding Hospital
Yantai, China
General Hospital of Ningxia Medical University
Yinchuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.